Skip to main content
Top
Published in: Tumor Biology 11/2016

01-11-2016 | Original Article

U/G SNP rs111904020 in 3′UTR of STAT3 regulated by miR-214 promotes hepatocellular carcinoma development in Chinese population

Authors: Ye Fan, Xiaofeng Qian, Chuanyong Zhang

Published in: Tumor Biology | Issue 11/2016

Login to get access

Abstract

STAT3 is an oncogene which mainly capable of regulating various biological characters by its transcriptional factor features driving thousands of genes. However, its upstream noncoding RNA-related regulations still remain unknown. In this study, we focused on the microRNA (miRNA)-associated single nucleotide polymorphisms (SNPs) in the 3′ unstranslated region (UTR) of STAT3 to investigate the further relationship of the SNPs with miRNAs among Chinese patients with hepatocellular carcinoma (HCC). We found that patients suffering from HBV infection indicated to be the susceptible population by comparing with controls. Besides, SNP rs111904020 (U/G) in STAT3, 3′UTR was involved in the occurrence of HCC by acting as tumor promoter factors. SNP rs111904020 (U/G) could be regulated by miR-214 which caused an upregulation of STAT3. Furthermore, the carriers of G genotype was related to high expression of STAT3, and larger tumor size as well as high probability of metastasis. Moreover, the SNP of U/G was associated with poor survival and high reoccurrence of HCC with a 5-year follow-up study. In conclusion, our findings have shown that the SNP rs111904020 (U/G) in STAT3 3′UTR acted as promotion factors in the HCC development through disrupting the regulatory role of miR-214 in STAT3 expression.
Literature
3.
go back to reference Banerjee K, Resat H. Constitutive activation of STAT3 in breast cancer cells: a review. International journal of cancer Journal international du cancer. 2015. doi:10.1002/ijc.29923. Banerjee K, Resat H. Constitutive activation of STAT3 in breast cancer cells: a review. International journal of cancer Journal international du cancer. 2015. doi:10.​1002/​ijc.​29923.
10.
go back to reference Zhang Y, Wei W, Cheng N, Wang K, Li B, Jiang X, et al. Hepatitis C virus-induced up-regulation of microRNA-155 promotes hepatocarcinogenesis by activating Wnt signaling. Hepatology. 2012;56(5):1631–40. doi:10.1002/hep.25849.CrossRefPubMed Zhang Y, Wei W, Cheng N, Wang K, Li B, Jiang X, et al. Hepatitis C virus-induced up-regulation of microRNA-155 promotes hepatocarcinogenesis by activating Wnt signaling. Hepatology. 2012;56(5):1631–40. doi:10.​1002/​hep.​25849.CrossRefPubMed
11.
12.
go back to reference Sentinelli F, Filippi E, Fallarino M, Romeo S, Fanelli M, Buzzetti R, et al. The 3′-UTR C>T polymorphism of the oxidized LDL-receptor 1 (OLR1) gene does not associate with coronary artery disease in Italian CAD patients or with the severity of coronary disease. Nutrition, metabolism, and cardiovascular diseases: NMCD. 2006;16(5):345–52. doi:10.1016/j.numecd.2005.06.002.CrossRefPubMed Sentinelli F, Filippi E, Fallarino M, Romeo S, Fanelli M, Buzzetti R, et al. The 3′-UTR C>T polymorphism of the oxidized LDL-receptor 1 (OLR1) gene does not associate with coronary artery disease in Italian CAD patients or with the severity of coronary disease. Nutrition, metabolism, and cardiovascular diseases: NMCD. 2006;16(5):345–52. doi:10.​1016/​j.​numecd.​2005.​06.​002.CrossRefPubMed
14.
go back to reference GoDarts, Group UDPS, Wellcome Trust Case Control C, Zhou K, Bellenguez C, Spencer CC, et al. Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes. Nat Genet. 2011;43(2):117–20. doi:10.1038/ng.735.CrossRef GoDarts, Group UDPS, Wellcome Trust Case Control C, Zhou K, Bellenguez C, Spencer CC, et al. Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes. Nat Genet. 2011;43(2):117–20. doi:10.​1038/​ng.​735.CrossRef
20.
go back to reference Deguchi A. Curcumin targets in inflammation and cancer. Endocrine, metabolic & immune disorders drug targets. 2015;15(2):88–96.CrossRef Deguchi A. Curcumin targets in inflammation and cancer. Endocrine, metabolic & immune disorders drug targets. 2015;15(2):88–96.CrossRef
21.
go back to reference Rybak AP, Bristow RG, Kapoor A. Prostate cancer stem cells: deciphering the origins and pathways involved in prostate tumorigenesis and aggression. Oncotarget. 2015;6(4):1900–19.CrossRefPubMed Rybak AP, Bristow RG, Kapoor A. Prostate cancer stem cells: deciphering the origins and pathways involved in prostate tumorigenesis and aggression. Oncotarget. 2015;6(4):1900–19.CrossRefPubMed
22.
Metadata
Title
U/G SNP rs111904020 in 3′UTR of STAT3 regulated by miR-214 promotes hepatocellular carcinoma development in Chinese population
Authors
Ye Fan
Xiaofeng Qian
Chuanyong Zhang
Publication date
01-11-2016
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 11/2016
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-016-5352-z

Other articles of this Issue 11/2016

Tumor Biology 11/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine